Mometasone Furoate: Uses and Dosages
Mometasone furoate is a medium-potency synthetic corticosteroid available in multiple formulations for treating various inflammatory conditions, with specific dosages and indications depending on the formulation and condition being treated. 1, 2
Topical Formulations
Indications
- Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses 1
- Effective for treating:
Dosage and Administration
- Topical solution/lotion (0.1%): Apply a few drops to affected areas once daily and massage lightly until it disappears 1
- For most effective use, hold nozzle close to affected area and gently squeeze 1
- Treatment duration: Discontinue when control is achieved; reassess diagnosis if no improvement after 2 weeks 1
- Not recommended for pediatric patients under 12 years of age 1
Special Considerations
- Should not be used with occlusive dressings unless directed by physician 1
- Avoid application in diaper area if patient requires diapers or plastic pants (may constitute occlusive dressing) 1
- Can be used in combination with other agents:
Intranasal Formulation
Indications
Dosage and Administration
- Nasal spray (50 μg per spray):
Efficacy
- Onset of action approximately 7 hours in seasonal allergic rhinitis 4
- As effective as twice-daily beclomethasone dipropionate or once-daily fluticasone propionate in perennial allergic rhinitis 4
- More effective than placebo in controlling symptoms of moderate to severe seasonal or perennial allergic rhinitis 4
Inhaled Formulation for Asthma
Indications
- Control of mild to severe persistent asthma in adults and adolescents 5
Dosage and Administration
- Dry powder inhaler (200 μg per inhalation):
Efficacy
- Improves lung function, asthma symptom scores, and reduces rescue medication use 5
- Can reduce requirements for oral corticosteroids in patients with oral corticosteroid-dependent asthma 5
Advantages and Safety Profile
Advantages
- Once-daily application for topical formulations (versus multiple daily applications for many other corticosteroids) 2, 6
- Low potential for causing primary sensitization and cross-reactions with other topical glucocorticoids 2
- Minimal systemic activity when used as directed 2, 4
- Low atrophogenic potential compared to other glucocorticoids in its class 2
Common Side Effects
- Topical: Transient mild to moderate local effects such as burning, stinging, folliculitis, dryness, acneiform eruptions 2
- Intranasal: Headache, pharyngitis, epistaxis, nasal irritation/burning 3, 4
- Inhaled: Oral candidiasis, headache, pharyngitis, dysphonia 5
Special Populations
Pregnancy and Lactation
- Moisturizers (which can be used with mometasone) are considered safe during pregnancy and lactation 3
Pediatric Use
- Not recommended for topical use in children under 12 years 1
- Intranasal formulation approved for children as young as 2 years 3
- Salicylic acid (sometimes combined with mometasone) should be avoided in children due to greater risk of systemic absorption and toxicity 3
Clinical Pearls
- For pruritus treatment, topical mometasone furoate 0.1% ointment or betamethasone valerate 0.1% ointment can be considered for moderate to high-potency steroid needs 3
- For psoriasis, combination therapy of mometasone with tazarotene may provide synergistic effects, increasing efficacy during therapy and duration of therapeutic effect 3
- In allergic rhinitis, patient preference between oral antihistamines and nasal steroids like mometasone should be considered to promote better adherence to therapy 3